Fort, D J <br/><br/>
Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.  [electronic resource] 

 -  Teratogenesis, carcinogenesis, and mutagenesis  2000 
 - 35-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-3211 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1520-6866(2000)20:1<35::aid-tcm4>3.0.co;2-i  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amitrole--pharmacology<br/>Animals<br/>Benzoflavones--pharmacology<br/>Biotransformation<br/>Cyclohexanes--pharmacology<br/>Cyclohexenes<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Embryo, Nonmammalian--drug effects<br/>Embryonic Development<br/>Enzyme Inhibitors--pharmacology<br/>Extremities--embryology<br/>Male<br/>Microsomes, Liver--drug effects<br/>No-Observed-Adverse-Effect Level<br/>Rats<br/>Rats, Sprague-Dawley<br/>Teratogens--metabolism<br/>Thalidomide--metabolism<br/>Toxicity Tests--methods<br/>Xenopus laevis--embryology